Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ringer lactate + propofol is a non-standard combination of two agents commonly used in anesthesia and perioperative care. Ringer lactate (also known as Lactated Ringer's solution) is an isotonic intravenous fluid containing sodium chloride, sodium lactate, potassium chloride, and calcium chloride, primarily used for fluid resuscitation and electrolyte balance. Propofol is a small molecule intravenous anesthetic agent used for induction and maintenance of general anesthesia or sedation. The combination may be encountered in clinical settings where both agents are administered concurrently (e.g., during surgery), but they are not formulated together as a single pharmaceutical product due to incompatibility issues when mixed directly. Mechanistically, Ringer lactate acts by restoring intravascular volume and correcting electrolyte imbalances; propofol acts primarily as a positive allosteric modulator of the GABA-A receptor in the central nervous system, producing sedative-hypnotic effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ringer lactate + propofol.